United States Weight Loss Drugs Market Report 2018

March 2018 | 110 pages | ID: U9DFAD518FDEN
QYResearch

Abstracts

In this report, the United States Weight Loss Drugs market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Weight Loss Drugs in these regions, from 2013 to 2025 (forecast).

United States Weight Loss Drugs market competition by top manufacturers/players, with Weight Loss Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Roche
• GSK group
• Teva
• Sandoz(Novartis)
• STADA-VN J.V.Co., Ltd
• Hexal AG
• National Company For Pharmaceutical Industry
• Lunan Pharmaceutical Group Corporation
• Zein Pharmaceutical
• Hisun
• Taj Pharmaceuticals Ltd
• Kabir Life Sciences & Research
• Dm Pharma
• China Zhongshan Pharm

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Liauid
• Tablets

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Weight-reducing Aid
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Weight Loss Drugs Market Report 2018

1 WEIGHT LOSS DRUGS OVERVIEW

1.1 Product Overview and Scope of Weight Loss Drugs
1.2 Classification of Weight Loss Drugs by Product Category
  1.2.1 United States Weight Loss Drugs Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Weight Loss Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Liauid
  1.2.4 Tablets
1.3 United States Weight Loss Drugs Market by Application/End Users
  1.3.1 United States Weight Loss Drugs Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Weight-reducing Aid
  1.3.3 Other
1.4 United States Weight Loss Drugs Market by Region
  1.4.1 United States Weight Loss Drugs Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Weight Loss Drugs Status and Prospect (2013-2025)
  1.4.3 Southwest Weight Loss Drugs Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Weight Loss Drugs Status and Prospect (2013-2025)
  1.4.5 New England Weight Loss Drugs Status and Prospect (2013-2025)
  1.4.6 The South Weight Loss Drugs Status and Prospect (2013-2025)
  1.4.7 The Midwest Weight Loss Drugs Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Weight Loss Drugs (2013-2025)
  1.5.1 United States Weight Loss Drugs Sales and Growth Rate (2013-2025)
  1.5.2 United States Weight Loss Drugs Revenue and Growth Rate (2013-2025)

2 UNITED STATES WEIGHT LOSS DRUGS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Weight Loss Drugs Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Weight Loss Drugs Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Weight Loss Drugs Average Price by Players/Suppliers (2013-2018)
2.4 United States Weight Loss Drugs Market Competitive Situation and Trends
  2.4.1 United States Weight Loss Drugs Market Concentration Rate
  2.4.2 United States Weight Loss Drugs Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Weight Loss Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES WEIGHT LOSS DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Weight Loss Drugs Sales and Market Share by Region (2013-2018)
3.2 United States Weight Loss Drugs Revenue and Market Share by Region (2013-2018)
3.3 United States Weight Loss Drugs Price by Region (2013-2018)

4 UNITED STATES WEIGHT LOSS DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Weight Loss Drugs Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Weight Loss Drugs Revenue and Market Share by Type (2013-2018)
4.3 United States Weight Loss Drugs Price by Type (2013-2018)
4.4 United States Weight Loss Drugs Sales Growth Rate by Type (2013-2018)

5 UNITED STATES WEIGHT LOSS DRUGS SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Weight Loss Drugs Sales and Market Share by Application (2013-2018)
5.2 United States Weight Loss Drugs Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES WEIGHT LOSS DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Roche
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Weight Loss Drugs Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Roche Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 GSK group
  6.2.2 Weight Loss Drugs Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 GSK group Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Teva
  6.3.2 Weight Loss Drugs Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Teva Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Sandoz(Novartis)
  6.4.2 Weight Loss Drugs Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Sandoz(Novartis) Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 STADA-VN J.V.Co., Ltd
  6.5.2 Weight Loss Drugs Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 STADA-VN J.V.Co., Ltd Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Hexal AG
  6.6.2 Weight Loss Drugs Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Hexal AG Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 National Company For Pharmaceutical Industry
  6.7.2 Weight Loss Drugs Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 National Company For Pharmaceutical Industry Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Lunan Pharmaceutical Group Corporation
  6.8.2 Weight Loss Drugs Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Lunan Pharmaceutical Group Corporation Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Zein Pharmaceutical
  6.9.2 Weight Loss Drugs Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Zein Pharmaceutical Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Hisun
  6.10.2 Weight Loss Drugs Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Hisun Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview
6.11 Taj Pharmaceuticals Ltd
6.12 Kabir Life Sciences & Research
6.13 Dm Pharma
6.14 China Zhongshan Pharm

7 WEIGHT LOSS DRUGS MANUFACTURING COST ANALYSIS

7.1 Weight Loss Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Weight Loss Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Weight Loss Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Weight Loss Drugs Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES WEIGHT LOSS DRUGS MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Weight Loss Drugs Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Weight Loss Drugs Sales Volume Forecast by Type (2018-2025)
11.3 United States Weight Loss Drugs Sales Volume Forecast by Application (2018-2025)
11.4 United States Weight Loss Drugs Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Weight Loss Drugs
Figure United States Weight Loss Drugs Market Size (K Tablets) by Type (2013-2025)
Figure United States Weight Loss Drugs Sales Volume Market Share by Type (Product Category) in 2017
Figure Liauid Product Picture
Figure Tablets Product Picture
Figure United States Weight Loss Drugs Market Size (K Tablets) by Application (2013-2025)
Figure United States Sales Market Share of Weight Loss Drugs by Application in 2017
Figure Weight-reducing Aid Examples
Table Key Downstream Customer in Weight-reducing Aid
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Weight Loss Drugs Market Size (Million USD) by Region (2013-2025)
Figure The West Weight Loss Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Weight Loss Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Weight Loss Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Weight Loss Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Weight Loss Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Weight Loss Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Weight Loss Drugs Sales (K Tablets) and Growth Rate (2013-2025)
Figure United States Weight Loss Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Weight Loss Drugs Market Major Players Product Sales Volume (K Tablets) (2013-2018)
Table United States Weight Loss Drugs Sales (K Tablets) of Key Players/Suppliers (2013-2018)
Table United States Weight Loss Drugs Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Weight Loss Drugs Sales Share by Players/Suppliers
Figure 2017 United States Weight Loss Drugs Sales Share by Players/Suppliers
Figure United States Weight Loss Drugs Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Weight Loss Drugs Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Weight Loss Drugs Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Weight Loss Drugs Revenue Share by Players/Suppliers
Figure 2017 United States Weight Loss Drugs Revenue Share by Players/Suppliers
Table United States Market Weight Loss Drugs Average Price (USD/Tablet) of Key Players/Suppliers (2013-2018)
Figure United States Market Weight Loss Drugs Average Price (USD/Tablet) of Key Players/Suppliers in 2017
Figure United States Weight Loss Drugs Market Share of Top 3 Players/Suppliers
Figure United States Weight Loss Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Weight Loss Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Weight Loss Drugs Product Category
Table United States Weight Loss Drugs Sales (K Tablets) by Region (2013-2018)
Table United States Weight Loss Drugs Sales Share by Region (2013-2018)
Figure United States Weight Loss Drugs Sales Share by Region (2013-2018)
Figure United States Weight Loss Drugs Sales Market Share by Region in 2017
Table United States Weight Loss Drugs Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Weight Loss Drugs Revenue Share by Region (2013-2018)
Figure United States Weight Loss Drugs Revenue Market Share by Region (2013-2018)
Figure United States Weight Loss Drugs Revenue Market Share by Region in 2017
Table United States Weight Loss Drugs Price (USD/Tablet) by Region (2013-2018)
Table United States Weight Loss Drugs Sales (K Tablets) by Type (2013-2018)
Table United States Weight Loss Drugs Sales Share by Type (2013-2018)
Figure United States Weight Loss Drugs Sales Share by Type (2013-2018)
Figure United States Weight Loss Drugs Sales Market Share by Type in 2017
Table United States Weight Loss Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Weight Loss Drugs Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Weight Loss Drugs by Type (2013-2018)
Figure Revenue Market Share of Weight Loss Drugs by Type in 2017
Table United States Weight Loss Drugs Price (USD/Tablet) by Types (2013-2018)
Figure United States Weight Loss Drugs Sales Growth Rate by Type (2013-2018)
Table United States Weight Loss Drugs Sales (K Tablets) by Application (2013-2018)
Table United States Weight Loss Drugs Sales Market Share by Application (2013-2018)
Figure United States Weight Loss Drugs Sales Market Share by Application (2013-2018)
Figure United States Weight Loss Drugs Sales Market Share by Application in 2017
Table United States Weight Loss Drugs Sales Growth Rate by Application (2013-2018)
Figure United States Weight Loss Drugs Sales Growth Rate by Application (2013-2018)
Table Roche Basic Information List
Table Roche Weight Loss Drugs Sales (K Tablets), Revenue (Million USD), Price (USD/Tablet) and Gross Margin (2013-2018)
Figure Roche Weight Loss Drugs Sales Growth Rate (2013-2018)
Figure Roche Weight Loss Drugs Sales Market Share in United States (2013-2018)
Figure Roche Weight Loss Drugs Revenue Market Share in United States (2013-2018)
Table GSK group Basic Information List
Table GSK group Weight Loss Drugs Sales (K Tablets), Revenue (Million USD), Price (USD/Tablet) and Gross Margin (2013-2018)
Figure GSK group Weight Loss Drugs Sales Growth Rate (2013-2018)
Figure GSK group Weight Loss Drugs Sales Market Share in United States (2013-2018)
Figure GSK group Weight Loss Drugs Revenue Market Share in United States (2013-2018)
Table Teva Basic Information List
Table Teva Weight Loss Drugs Sales (K Tablets), Revenue (Million USD), Price (USD/Tablet) and Gross Margin (2013-2018)
Figure Teva Weight Loss Drugs Sales Growth Rate (2013-2018)
Figure Teva Weight Loss Drugs Sales Market Share in United States (2013-2018)
Figure Teva Weight Loss Drugs Revenue Market Share in United States (2013-2018)
Table Sandoz(Novartis) Basic Information List
Table Sandoz(Novartis) Weight Loss Drugs Sales (K Tablets), Revenue (Million USD), Price (USD/Tablet) and Gross Margin (2013-2018)
Figure Sandoz(Novartis) Weight Loss Drugs Sales Growth Rate (2013-2018)
Figure Sandoz(Novartis) Weight Loss Drugs Sales Market Share in United States (2013-2018)
Figure Sandoz(Novartis) Weight Loss Drugs Revenue Market Share in United States (2013-2018)
Table STADA-VN J.V.Co., Ltd Basic Information List
Table STADA-VN J.V.Co., Ltd Weight Loss Drugs Sales (K Tablets), Revenue (Million USD), Price (USD/Tablet) and Gross Margin (2013-2018)
Figure STADA-VN J.V.Co., Ltd Weight Loss Drugs Sales Growth Rate (2013-2018)
Figure STADA-VN J.V.Co., Ltd Weight Loss Drugs Sales Market Share in United States (2013-2018)
Figure STADA-VN J.V.Co., Ltd Weight Loss Drugs Revenue Market Share in United States (2013-2018)
Table Hexal AG Basic Information List
Table Hexal AG Weight Loss Drugs Sales (K Tablets), Revenue (Million USD), Price (USD/Tablet) and Gross Margin (2013-2018)
Figure Hexal AG Weight Loss Drugs Sales Growth Rate (2013-2018)
Figure Hexal AG Weight Loss Drugs Sales Market Share in United States (2013-2018)
Figure Hexal AG Weight Loss Drugs Revenue Market Share in United States (2013-2018)
Table National Company For Pharmaceutical Industry Basic Information List
Table National Company For Pharmaceutical Industry Weight Loss Drugs Sales (K Tablets), Revenue (Million USD), Price (USD/Tablet) and Gross Margin (2013-2018)
Figure National Company For Pharmaceutical Industry Weight Loss Drugs Sales Growth Rate (2013-2018)
Figure National Company For Pharmaceutical Industry Weight Loss Drugs Sales Market Share in United States (2013-2018)
Figure National Company For Pharmaceutical Industry Weight Loss Drugs Revenue Market Share in United States (2013-2018)
Table Lunan Pharmaceutical Group Corporation Basic Information List
Table Lunan Pharmaceutical Group Corporation Weight Loss Drugs Sales (K Tablets), Revenue (Million USD), Price (USD/Tablet) and Gross Margin (2013-2018)
Figure Lunan Pharmaceutical Group Corporation Weight Loss Drugs Sales Growth Rate (2013-2018)
Figure Lunan Pharmaceutical Group Corporation Weight Loss Drugs Sales Market Share in United States (2013-2018)
Figure Lunan Pharmaceutical Group Corporation Weight Loss Drugs Revenue Market Share in United States (2013-2018)
Table Zein Pharmaceutical Basic Information List
Table Zein Pharmaceutical Weight Loss Drugs Sales (K Tablets), Revenue (Million USD), Price (USD/Tablet) and Gross Margin (2013-2018)
Figure Zein Pharmaceutical Weight Loss Drugs Sales Growth Rate (2013-2018)
Figure Zein Pharmaceutical Weight Loss Drugs Sales Market Share in United States (2013-2018)
Figure Zein Pharmaceutical Weight Loss Drugs Revenue Market Share in United States (2013-2018)
Table Hisun Basic Information List
Table Hisun Weight Loss Drugs Sales (K Tablets), Revenue (Million USD), Price (USD/Tablet) and Gross Margin (2013-2018)
Figure Hisun Weight Loss Drugs Sales Growth Rate (2013-2018)
Figure Hisun Weight Loss Drugs Sales Market Share in United States (2013-2018)
Figure Hisun Weight Loss Drugs Revenue Market Share in United States (2013-2018)
Table Taj Pharmaceuticals Ltd Basic Information List
Table Kabir Life Sciences & Research Basic Information List
Table Dm Pharma Basic Information List
Table China Zhongshan Pharm Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Weight Loss Drugs
Figure Manufacturing Process Analysis of Weight Loss Drugs
Figure Weight Loss Drugs Industrial Chain Analysis
Table Raw Materials Sources of Weight Loss Drugs Major Players/Suppliers in 2017
Table Major Buyers of Weight Loss Drugs
Table Distributors/Traders List
Figure United States Weight Loss Drugs Sales Volume (K Tablets) and Growth Rate Forecast (2018-2025)
Figure United States Weight Loss Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Weight Loss Drugs Price (USD/Tablet) Trend Forecast (2018-2025)
Table United States Weight Loss Drugs Sales Volume (K Tablets) Forecast by Type (2018-2025)
Figure United States Weight Loss Drugs Sales Volume (K Tablets) Forecast by Type (2018-2025)
Figure United States Weight Loss Drugs Sales Volume (K Tablets) Forecast by Type in 2025
Table United States Weight Loss Drugs Sales Volume (K Tablets) Forecast by Application (2018-2025)
Figure United States Weight Loss Drugs Sales Volume (K Tablets) Forecast by Application (2018-2025)
Figure United States Weight Loss Drugs Sales Volume (K Tablets) Forecast by Application in 2025
Table United States Weight Loss Drugs Sales Volume (K Tablets) Forecast by Region (2018-2025)
Table United States Weight Loss Drugs Sales Volume Share Forecast by Region (2018-2025)
Figure United States Weight Loss Drugs Sales Volume Share Forecast by Region (2018-2025)
Figure United States Weight Loss Drugs Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources